Key statistics
As of last trade Insulet Corp (GOV:FRA) traded at 250.70, -4.02% below its 52-week high of 261.20, set on Nov 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 250.30 |
---|---|
High | 250.70 |
Low | 250.30 |
Bid | 250.30 |
Offer | 252.40 |
Previous close | 252.10 |
Average volume | 51.22 |
---|---|
Shares outstanding | 70.14m |
Free float | 69.76m |
P/E (TTM) | 46.34 |
Market cap | 18.70bn USD |
EPS (TTM) | 5.75 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 14:41 GMT.
More ▼
- Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S.
- Insulet to Present at Upcoming Investor Conferences
- Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency¹)
- Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November
- Omnipod® 5 App for iPhone® Now Fully Available in the United States
- Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors
- Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024
- Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes
More ▼